Was this GSK trial done with ILNS Conjumab AMD program? GSK completed GSK933776 (anti Aß peptide, n-terminus ) AMD phase 2 trial last month. Enrolment: 190 https://clinicaltrials.gov/ct2/show/NCT01342926?term=gsk933776&rank=4